HER2 regulated miRNA expression in letrozole resistant breast cancer

被引：4
|
作者：
Kazi, Armina A. [1 ]
Sabnis, Gauri [1 ]
Zhou, Qun [1 ]
Chumsri, Saranya [1 ]
Schech, Amanda [1 ]
Shah, Preeti [1 ]
Brodie, Angela [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1471
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1471
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Breast Cancer and HER2 Over Expression
    Devgan, Manish
    Mohan, Ankur
    Gangwar, Pallavi
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2014, 3 (05): : 395 - 398
  • [2] Examination of low Her2 expression in breast cancer
    Fernandez, Aileen I.
    Liu, Matthew
    Bellizzi, Andrew
    Brock, Jane
    Fadare, Oluwole
    Hanley, Krisztina
    Harigopal, Malini
    Jorns, Julie M.
    Kuba, M. Gabriela
    Ly, Amy
    Podoll, Mirna
    Rabe, Kimmie
    Sanders, Mary Ann
    Singh, Kamaljeet
    Snir, Olivia L.
    Soong, Rinda
    Wei, Shi
    Wen, Hannah
    Wong, Serena
    Yoon, Esther
    Pusztai, Lajos
    Reisenbichler, Emily
    Rimm, David L.
    CANCER RESEARCH, 2022, 82 (04)
  • [3] Expression and purification of breast cancer marker HER2
    Turgimbayeva, Aigerim
    Abeldenov, Sailau
    Sarina, Nurgul
    Ramanculov, Erlan
    Eskendirova, Saule
    Khassenov, Bekbolat
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S90 - S91
  • [4] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen
    Rehmus, Esther Hoogland
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen Awad
    Rehmus, Esther Hoogland
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [6] HER2 Expression in Breast Cancer With Nonamplified HER2 and Gains of Chromosome 17 Centromere
    Panvichian, Ravat
    Tantiwetrueangdet, Anchalee
    Wongwaisayawan, Sansanee
    Nampoon, Amporn
    Lertsithichai, Panuwat
    Leelaudomlipi, Surasak
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (04) : 367 - 374
  • [7] Involvement of HER2, HIF-1, and BCRP in cancer stem cell characteristics of letrozole-resistant breast cancer cells
    Gilani, Rabia
    Kazi, Armina A.
    Scheh, Amanda
    Chumsri, Saranya
    Shah, Preeti
    Brodie, Angela
    CANCER RESEARCH, 2012, 72
  • [8] Differential response of HER2 positive breast cancer based on HER2 protein expression level
    Atallah, N. M.
    Toss, M. S.
    Al Saleem, M.
    Green, A. R.
    Mongan, N. P.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2023, 261 : S9 - S9
  • [9] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Isabel Pinhel
    Margaret Hills
    Suzanne Drury
    Janine Salter
    Georges Sumo
    Roger A'Hern
    Judith M Bliss
    Ivana Sestak
    Jack Cuzick
    Peter Barrett-Lee
    Adrian Harris
    Mitch Dowsett
    Breast Cancer Research, 14
  • [10] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
12345